Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. The classification of pain management drugs includes Opioids and Non-narcotic Analgesics. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone, hydrocodone, codeine, morphine, and many others. Non-narcotic Analgesics include NSAIDS, anticonvulsants, anti-depressants and others. And thie report is mainly studies of Pain Management madications.
This report contains market size and forecasts of Pain Management Product in global, including the following market information:
Global Pain Management Product Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pain Management Product Market Sales, 2017-2022, 2023-2028, (MT)
Global top five Pain Management Product companies in 2021 (%)
The global Pain Management Product market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Opioids Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pain Management Product include Pfizer, GSK, Novartis, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pain Management Product manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pain Management Product Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Pain Management Product Market Segment Percentages, by Type, 2021 (%)
Opioids
Non-narcotic Analgesics
Global Pain Management Product Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Pain Management Product Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Homecare
Global Pain Management Product Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global Pain Management Product Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pain Management Product revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pain Management Product revenues share in global market, 2021 (%)
Key companies Pain Management Product sales in global market, 2017-2022 (Estimated), (MT)
Key companies Pain Management Product sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
GSK
Novartis
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Merck
Depomed
Yunnan Baiyao
Teva
Johnson & Johnson
Allergan
Purdue Pharma